Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Michal London"'
Autor:
Gilad W. Vainer, Judith Sandbank, Yaniv Zohar, Tzahi Neuman, Juliane Kania-Almog, Michal London, Iris Barshak, Anna Litvin, Ludmila Fridel
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 11(11)
Immunotherapy is a novel treatment for lung cancer. Pembrolizumab (Merck Sharp and Dohme, Kenilworth, NJ) is a monoclonal antibody against programmed cell death 1 that has been approved for use with NSCLC together with a companion diagnostic by Dako